Cargando…

Long‐term prognosis in breast cancer is associated with residual disease after neoadjuvant systemic therapy but not with initial nodal status

BACKGROUND: This follow‐up analysis of a Swedish prospective multicentre trial had the primary aim to determine invasive disease‐free (IDFS), breast cancer‐specific (BCSS) and overall survival (OS) rates, and their association with axillary staging results before and after neoadjuvant systemic thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zetterlund, L, Celebioglu, F, Hatschek, T, Frisell, J, de Boniface, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364852/ https://www.ncbi.nlm.nih.gov/pubmed/34043772 http://dx.doi.org/10.1002/bjs.11963

Ejemplares similares

Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer
por: Zetterlund, Linda Holmstrand, et al.
Publicado: (2017)

Swedish prospective multicenter trial on the accuracy and clinical relevance of sentinel lymph node biopsy before neoadjuvant systemic therapy in breast cancer
por: Zetterlund, Linda, et al.
Publicado: (2017)

Accuracy of breast MRI in evaluating nodal status after neoadjuvant therapy in invasive lobular carcinoma
por: Abel, Mary Kathryn, et al.
Publicado: (2021)

Regional nodal irradiation (RNI) in breast cancer patients with residual isolated tumor cells or micrometastatic nodal disease after neoadjuvant chemotherapy
por: Kim, Joseph K., et al.
Publicado: (2022)

Prognostic significance of residual nodal disease after neoadjuvant endocrine therapy for hormone receptor-positive breast cancer
por: Kantor, Olga, et al.
Publicado: (2020)

Internal mammary lymph nodal response to neoadjuvant chemotherapy on imaging and breast cancer prognosis
por: Adam, Richard, et al.
Publicado: (2022)

Sentinel node biopsy alone for breast cancer patients with residual nodal disease after neoadjuvant chemotherapy
por: Chun, Jung Whan, et al.
Publicado: (2021)

Socioeconomic status differs between breast cancer patients treated with mastectomy and breast conservation, and affects patient-reported preoperative information
por: Frisell, A., et al.
Publicado: (2019)

Influence of socioeconomic status on immediate breast reconstruction rate, patient information and involvement in surgical decision‐making
por: Frisell, A., et al.
Publicado: (2020)

Prognosis based on primary breast carcinoma instead of pathological nodal status.
por: Ménard, S., et al.
Publicado: (1994)

Prediction of Non-Sentinel Lymph Node Status in Breast Cancer Patients with Sentinel Lymph Node Metastases: Evaluation of the Tenon Score
por: Andersson, Y, et al.
Publicado: (2012)

Impact of Postmastectomy Radiation Therapy on Breast Cancer Patients According to Pathologic Nodal Status after Modern Neoadjuvant Chemotherapy
por: Kim, Dowook, et al.
Publicado: (2023)

Prediction of Residual Axillary Nodal Metastasis Following Neoadjuvant Chemotherapy for Breast Cancer: Radiomics Analysis Based on Chest Computed Tomography
por: Lee, Hyo-jae, et al.
Publicado: (2023)

Applicability of magnetic seeds for target lymph node biopsy after neoadjuvant chemotherapy in initially node-positive breast cancer patients: data from the AXSANA study
por: Hartmann, Steffi, et al.
Publicado: (2023)

Significance of intrinsic breast cancer subtypes on the long-term prognosis after neoadjuvant chemotherapy
por: Goto, Wataru, et al.
Publicado: (2018)

ASO Author Reflections: Residual Disease in the Breast Following Neoadjuvant Chemotherapy Does Not Mandate Routine Post-Mastectomy Radiation Therapy/Regional Nodal Irradiation
por: Crown, Angelena, et al.
Publicado: (2020)

Biomarker Dynamics and Long-Term Treatment Outcomes in Breast Cancer Patients with Residual Cancer Burden after Neoadjuvant Therapy
por: Holanek, Milos, et al.
Publicado: (2022)

National study of the impact of patient information and involvement in decision‐making on immediate breast reconstruction rates
por: Frisell, A., et al.
Publicado: (2016)

Impact of residual disease biomarkers on the prognosis of HER2‐positive breast cancer following neoadjuvant therapy
por: Ma, Youzhao, et al.
Publicado: (2023)

Breast‐conserving surgery followed by whole‐breast irradiation offers survival benefits over mastectomy without irradiation
por: de Boniface, J., et al.
Publicado: (2018)

Locoregional Recurrence Risk in Breast Cancer Patients with Estrogen Receptor Positive Tumors and Residual Nodal Disease following Neoadjuvant Chemotherapy and Mastectomy without Radiation Therapy
por: Kandula, Shravan, et al.
Publicado: (2015)

Risk factors for implant failure following revision surgery in breast cancer patients with a previous immediate implant-based breast reconstruction
por: Frisell, A., et al.
Publicado: (2020)

SLN melanoma micrometastasis predictivity of nodal status: a long term retrospective study
por: Migliano, Emilia, et al.
Publicado: (2013)

Post-ablation prolongation of atrioventricular nodal refractory period is correlated with long-term success of cryoablation for atrioventricular nodal reentrant tachycardia in the case of the persistence of a residual jump
por: Tonet, Joelci, et al.
Publicado: (2012)

An objective nodal staging system for breast cancer patients undergoing neoadjuvant systemic treatment
por: Yoo, Tae-Kyung, et al.
Publicado: (2017)

The nodal positivity rate in breast pCR patients with initially, clinically node-negative breast cancer after neoadjuvant systemic therapy: A systematic review and meta-analysis
por: Ma, Le, et al.
Publicado: (2023)

Impact of receptor phenotype on nodal burden in patients with breast cancer who have undergone neoadjuvant chemotherapy
por: Boland, M. R., et al.
Publicado: (2017)

Survival in breast cancer patients with a delayed DIEP flap breast reconstruction after adjustment for socioeconomic status and comorbidity
por: Coudé Adam, H., et al.
Publicado: (2021)

False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy
por: de Boniface, Jana, et al.
Publicado: (2022)

MRI for nodal restaging after neoadjuvant therapy in rectal cancer with histopathologic comparison
por: Zhang, Zhiwen, et al.
Publicado: (2023)

Residual Axillary Burden After Neoadjuvant Chemotherapy (NACT) in Early Breast Cancer in Patients with a priori Clinically Occult Nodal Metastases – a transSENTINA Analysis
por: Kolberg, Hans-Christian, et al.
Publicado: (2020)

Do clinical trials truly mirror their target population? An external validity analysis of national register versus trial data from the Swedish prospective SENOMIC trial on sentinel node micrometastases in breast cancer
por: Andersson, Y., et al.
Publicado: (2019)

Nomograms for preoperative prediction of axillary nodal status in breast cancer
por: Dihge, L., et al.
Publicado: (2017)

Determination of breast cancer prognosis after neoadjuvant chemotherapy: comparison of Residual Cancer Burden (RCB) and Neo-Bioscore
por: Laas, Enora, et al.
Publicado: (2021)

Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients
por: Yau, Christina, et al.
Publicado: (2022)

Correction: Residual Axillary Burden After Neoadjuvant Chemotherapy (NACT) in Early Breast Cancer in Patients with a priori Clinically Occult Nodal Metastases – a transSENTINA Analysis
por: Kolberg, Hans-Christian, et al.
Publicado: (2020)

Long-term outcomes of implant-based immediate breast reconstruction with and without radiotherapy: a population-based study
por: de Boniface, Jana, et al.
Publicado: (2022)

Assessment of preoperative axillary nodal disease burden: breast MRI in locally advanced breast cancer before, during and after neoadjuvant endocrine therapy
por: Reis, Joana, et al.
Publicado: (2022)

Tumor Size Still Impacts Prognosis in Breast Cancer With Extensive Nodal Involvement
por: Liu, Yin, et al.
Publicado: (2021)

Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer
por: Cascone, Tina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i8jjo0juk1j9g75rm51mmghqvm